S. Rosenberg Ellen's most recent trade in Amicus Therapeutics Inc was a trade of 64,800 Common Stock done . Disclosure was reported to the exchange on Feb. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 64,800 | 536,294 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.57 per share. | 11 Feb 2025 | 28,584 | 507,710 (0%) | 0% | 9.6 | 273,549 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 203,825 | 203,825 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 112,495 | 490,272 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.41 per share. | 02 Jan 2025 | 15,397 | 474,875 (0%) | 0% | 9.4 | 144,886 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.31 per share. | 02 Jan 2025 | 6,442 | 377,777 (0%) | 0% | 9.3 | 59,975 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.41 per share. | 02 Jan 2025 | 3,381 | 471,494 (0%) | 0% | 9.4 | 31,815 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 29,600 | 0 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Rosenberg Ellen S. | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.16 per share. | 06 Feb 2024 | 29,600 | 397,254 (0%) | 0% | 5.2 | 152,736 | Common Stock |
| Amicus Therapeutics Inc | Rosenberg Ellen S. | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 06 Feb 2024 | 29,600 | 367,654 (0%) | 0% | 13.0 | 384,818 | Common Stock |
| Amicus Therapeutics Inc | Rosenberg Ellen S. | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.16 per share. | 06 Feb 2024 | 400 | 368,054 (0%) | 0% | 5.2 | 2,064 | Common Stock |
| Amicus Therapeutics Inc | S. Rosenberg Ellen | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 06 Feb 2024 | 400 | 367,654 (0%) | 0% | 13 | 5,200 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 400 | 29,600 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2024 | 16,565 | 396,219 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | Ellen Rosenberg S. | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.65 per share. | 09 Jan 2024 | 12,000 | 367,654 (0%) | 0% | 13.7 | 163,800 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.65 per share. | 09 Jan 2024 | 12,000 | 384,219 (0%) | 0% | 13.7 | 163,800 | Common Stock |
| Amicus Therapeutics Inc | Rosenberg S. Ellen | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.44 per share. | 04 Jan 2024 | 3,380 | 379,654 (0%) | 0% | 13.4 | 45,427 | Common Stock |
| Amicus Therapeutics Inc | Ellen Rosenberg S. | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 108,980 | 108,980 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Rosenberg S. Ellen | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 63,131 | 405,416 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | Ellen Rosenberg S. | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 14.21 per share. | 02 Jan 2024 | 30,000 | 342,285 (0%) | 0% | 14.2 | 426,219 | Common Stock |
| Amicus Therapeutics Inc | Rosenberg S. Ellen | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.16 per share. | 02 Jan 2024 | 30,000 | 372,285 (0%) | 0% | 5.2 | 154,800 | Common Stock |
| Amicus Therapeutics Inc | Rosenberg S. Ellen | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2024 | 30,000 | 30,000 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | S. Rosenberg Ellen | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.53 per share. | 02 Jan 2024 | 15,397 | 383,034 (0%) | 0% | 13.5 | 208,321 | Common Stock |
| Amicus Therapeutics Inc | S. Rosenberg Ellen | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.24 per share. | 02 Jan 2024 | 6,985 | 398,431 (0%) | 0% | 14.2 | 99,466 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Dec 2023 | 30,000 | 65,000 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Rosenberg Ellen S. | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 26 Dec 2023 | 30,000 | 342,285 (0%) | 0% | 14.0 | 420,084 | Common Stock |
| Amicus Therapeutics Inc | Ellen Rosenberg S. | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.16 per share. | 26 Dec 2023 | 30,000 | 372,285 (0%) | 0% | 5.2 | 154,800 | Common Stock |
| Amicus Therapeutics Inc | S. Ellen Rosenberg | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Dec 2023 | 5,000 | 60,000 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Rosenberg Ellen S. | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.16 per share. | 26 Dec 2023 | 5,000 | 347,285 (0%) | 0% | 5.2 | 25,800 | Common Stock |
| Amicus Therapeutics Inc | Ellen Rosenberg S. | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 14.07 per share. | 26 Dec 2023 | 5,000 | 342,285 (0%) | 0% | 14.1 | 70,327 | Common Stock |
| Amicus Therapeutics Inc | Ellen Rosenberg S. | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 9,940 | 342,285 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 13.32 per share. | 24 Jan 2023 | 31,839 | 332,345 (0%) | 0% | 13.3 | 424,006 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2023 | 56,024 | 388,369 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.02 per share. | 11 Jan 2023 | 24,185 | 364,184 (0%) | 0% | 12.0 | 290,704 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.03 per share. | 04 Jan 2023 | 3,575 | 332,345 (0%) | 0% | 12.0 | 43,007 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 138,008 | 138,008 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 77,749 | 343,813 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.21 per share. | 02 Jan 2023 | 14,643 | 266,064 (0%) | 0% | 12.2 | 178,791 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.93 per share. | 02 Jan 2023 | 7,893 | 335,920 (0%) | 0% | 11.9 | 94,163 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 10.02 per share. | 01 Aug 2022 | 11,123 | 280,707 (0%) | 0% | 10.0 | 111,472 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 21 Jun 2022 | 11,122 | 291,830 (0%) | 0% | 10.0 | 111,272 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 39,143 | 330,868 (0%) | 0% | - | Common Stock | |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.53 per share. | 14 Jan 2022 | 16,898 | 313,970 (0%) | 0% | 10.5 | 177,936 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2021 | 20,501 | 241,206 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 20,731 | 229,499 (0%) | 0% | - | Common Stock | |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.84 per share. | 15 Jan 2021 | 8,794 | 220,705 (0%) | 0% | 21.8 | 192,017 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 15.26 per share. | 16 Jul 2020 | 30,000 | 195,169 (0%) | 0% | 15.3 | 457,911 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.16 per share. | 16 Jul 2020 | 30,000 | 225,169 (0%) | 0% | 5.2 | 154,800 | Common Stock |
| Amicus Therapeutics Inc | Ellen S. Rosenberg | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2020 | 30,000 | 95,000 | - | - | Stock Options (right to buy) |